C.-H. Köhne

2.2k total citations
27 papers, 1.6k citations indexed

About

C.-H. Köhne is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, C.-H. Köhne has authored 27 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 5 papers in Pathology and Forensic Medicine. Recurrent topics in C.-H. Köhne's work include Colorectal Cancer Treatments and Studies (22 papers), Cancer Treatment and Pharmacology (13 papers) and Lung Cancer Treatments and Mutations (7 papers). C.-H. Köhne is often cited by papers focused on Colorectal Cancer Treatments and Studies (22 papers), Cancer Treatment and Pharmacology (13 papers) and Lung Cancer Treatments and Mutations (7 papers). C.-H. Köhne collaborates with scholars based in Germany, France and United States. C.-H. Köhne's co-authors include Bengt Glimelius, David Cunningham, P. Rougier, Patrick Schöffski, Gunnar Folprecht, Enrique Aranda, J. Wils, Werner Scheithauer, Francesco Di Costanzo and Hartmut Hecker and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

C.-H. Köhne

25 papers receiving 1.6k citations

Peers

C.-H. Köhne

ONCOL

PRM

HEPAT

SURGE

PFM

Élisabeth Carola France

Jeffrey P. Meyers United States

Karen Rittweger United States

A. Wong Canada

Carmelo Pozzo Italy

R. Adam France

J Pater Canada

Mario Barugel Argentina

Ferrán Losa Spain

May Mabro France

Élisabeth Carola France

C.-H. Köhne

2.2k ×1.6

ONCOL

852 ×1.5

PRM

680 ×1.6

HEPAT

415 ×1.2

SURGE

338 ×1.0

PFM

Citations per year, relative to C.-H. Köhne C.-H. Köhne (= 1×) peers Élisabeth Carola

Countries citing papers authored by C.-H. Köhne

Since Specialization

Citations

This map shows the geographic impact of C.-H. Köhne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.-H. Köhne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.-H. Köhne more than expected).

Fields of papers citing papers by C.-H. Köhne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.-H. Köhne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.-H. Köhne. The network helps show where C.-H. Köhne may publish in the future.

Co-authorship network of co-authors of C.-H. Köhne

This figure shows the co-authorship network connecting the top 25 collaborators of C.-H. Köhne. A scholar is included among the top collaborators of C.-H. Köhne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.-H. Köhne. C.-H. Köhne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fokas, Emmanouil, Rainer Fietkau, Arndt Hartmann, et al.. (2018). Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial. Annals of Oncology. 29(7). 1521–1527. 53 indexed citations

Bokemeyer, Carsten, C.-H. Köhne, Fortunato Ciardiello, et al.. (2015). FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancer. European Journal of Cancer. 51(10). 1243–1252. 181 indexed citations

Köhne, C.-H.. (2012). Current stages of adjuvant treatment of colon cancer. Annals of Oncology. 23. x71–x76. 9 indexed citations

Karthaus, Meinolf, Ralf‐Dieter Hofheinz, Laurent Mineur, et al.. (2009). Epidermal growth factor receptor (EGFR) inhibitor–related skin toxicity: Review of interim data from a phase II study (20060314) of panitumumab (pmab) with FOLFIRI in the first-line treatment of metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. 27(15_suppl). e20634–e20634. 6 indexed citations

Papamichael, D., Riccardo A. Audisio, Bengt Glimelius, et al.. (2008). Treatment of the elderly colorectal cancer patient: SIOG expert recommendations. Annals of Oncology. 20(1). 5–16. 134 indexed citations

Sørbye, Halfdan, C.-H. Köhne, Daniel J. Sargent, & Bengt Glimelius. (2007). Patient characteristics and stratification in medical treatment studies for metastatic colorectal cancer: A proposal for standardization of patient characteristic reporting and stratification. Annals of Oncology. 18(10). 1666–1672. 61 indexed citations

Cutsem, Eric Van, Marek P. Nowacki, István Láng, et al.. (2007). Randomized phase III study of irinotecan and 5-FU/FA with or without cetuximab in the first-line treatment of patients with metastatic colorectal cancer (mCRC): The CRYSTAL trial. Journal of Clinical Oncology. 25(18_suppl). 4000–4000. 233 indexed citations

Goldberg, Richard M., C.-H. Köhne, Michel Seymour, et al.. (2007). A pooled safety and efficacy analysis examining the effect of performance status (PS) on outcomes in nine first-line treatment (rx) trials (cts) of 6,286 patients (pts) with metastatic colorectal cancer (MCRC). Journal of Clinical Oncology. 25(18_suppl). 4011–4011. 7 indexed citations

Folprecht, Gunnar, Manfred P. Lutz, Patrick Schöffski, et al.. (2005). Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma. Annals of Oncology. 17(3). 450–456. 192 indexed citations

10.

Folprecht, Gunnar, David Cunningham, Paul J. Ross, et al.. (2004). Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials. Annals of Oncology. 15(9). 1330–1338. 190 indexed citations

11.

Folprecht, Gunnar, David Cunningham, Bengt Glimelius, et al.. (2004). Efficacy of bolus and infusional 5-FU in elderly and non-elderly patients with metastatic colorectal cancer - a pooled analysis of clinical trials. Journal of Clinical Oncology. 22(14_suppl). 8045–8045. 6 indexed citations

12.

Ducreux, Michel, C.-H. Köhne, G. K. Schwartz, & U. Vanhoefer. (2003). Irinotecan in metastatic colorectal cancer: dose intensification and combination with new agents, including biological response modifiers. Annals of Oncology. 14. ii17–ii23. 19 indexed citations

13.

Köhne, C.-H., David Cunningham, Francesco Di Costanzo, et al.. (2002). Clinical determinants of survival in patients with 5-fluorouracil- based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients. Annals of Oncology. 13(2). 308–317. 356 indexed citations

14.

Benter, T., et al.. (2001). Anatomical Variations in the Internal Jugular Veins of Cancer Patients Affecting Central Venous Access. Ultraschall in der Medizin - European Journal of Ultrasound. 22(1). 23–26. 29 indexed citations

15.

Petrowsky, Henrik, Isrid Sturm, David A. Kooby, et al.. (2001). Relevance of Ki-67 antigen expression and K- ras mutation in colorectal liver metastases. European Journal of Surgical Oncology. 27(1). 80–87. 81 indexed citations

16.

Köhne, C.-H., et al.. (2001). Adjuvante Behandlung von Patienten mit Rektumkarzinomen. Der Onkologe. 7(4). 400–411. 1 indexed citations

17.

Harstrick, A., C.-H. Köhne, Wolfgang Hiddemann, et al.. (1997). Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphon acetyl)-L-aspartate (PALA) is inactive in advanced pancreatic carcinoma. Annals of Oncology. 8(9). 917–918. 2 indexed citations

18.

Kretzschmar, Albrecht, C.-H. Köhne, & Bernd Dörken. (1997). Docetaxel in der Behandlung anderer solider Tumoren. Medizinische Klinik. 92(S4). 16–22. 2 indexed citations

19.

Köhne, C.-H., A. Harstrick, Wolfgang Hiddemann, et al.. (1997). Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphonacetyl)-l-aspartate in patients with advanced colorectal cancer. Results of a phase II study. European Journal of Cancer. 33(11). 1896–1899. 7 indexed citations

20.

Köhne, C.-H. & J. Wils. (1996). Is intra-arterial chemotherapy worthwhile in the treatment of patients with unresectable hepatic colorectal cancer metastases?. European Journal of Cancer. 32(13). 2197–2201. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact